Alexia is an experienced Australian and New Zealand intellectual property (IP) litigator. Alexia’s practice includes patent, trade mark and copyright infringement, patent and trade mark oppositions, breach of confidence, IP ownership disputes, misleading and deceptive conduct,  IP licensing, and pharmaceutical/medical device regulation. Alexia is experienced in acting for multi-national corporations in cross-border patent disputes and in pre-grant patent oppositions, with a notable examples being acting for Sanofi and Bristol Myers Squibb for more than a decade in patent infringement and revocation proceedings in relation to the blockbuster drug clopidogrel, and acting for Bayer NZ, Elanco and ResMed in various patent matters.

Originally from Australia, Alexia joined James & Wells in 2019. Prior to that, Alexia worked for more than 15 years as a litigator in the IP group at Allens (an Australian based international law firm), gaining significant experience in Federal Court and High Court proceedings.

She provides commercially relevant advice to clients in a wide range of industries, including pharmaceuticals, medical devices, animal health, food and beverages, and mining.

Alexia enjoys exploring New Zealand, music, paddle boarding, and spending time with her children.